Anaesthesia & intensive care medicine
Volume 10, Issue 4 , Pages 165-168 , April 2009

Sepsis and multiple organ failure

References 

  1. Levy MM, Fink MP, Marshall JC, et al. International Sepsis Definitions Conference 2001. Intensive Care Med. 2003;29:530–538
  2. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock 2008. Crit Care Med. 2008;36:296–327
  3. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377
  4. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709
  5. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862–871
  6. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111–124
  7. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–887

PII: S1472-0299(09)00027-7

doi: 10.1016/j.mpaic.2009.01.008

Anaesthesia & intensive care medicine
Volume 10, Issue 4 , Pages 165-168 , April 2009

Article Tools